- Home
- ZEPP vs HRTX Comparison
ZEPP vs HRTX Comparison
Compare ZEPP & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZEPP | HRTX |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 54.1M |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ZEPP | HRTX |
|---|---|---|
| Price | $2.81 | $0.32 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 70.4K | ★ 4.5M |
| Earning Date | 11-22-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $154,904,000.00 |
| Revenue This Year | $14.24 | N/A |
| Revenue Next Year | $6.50 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $2.15 | $0.26 |
| 52 Week High | $32.85 | $1.58 |
Technical Indicators
Market Signals| Indicator | ZEPP | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.33 | 49.48 |
| Support Level | $2.19 | $0.28 |
| Resistance Level | $5.57 | $0.34 |
| Average True Range (ATR) | 0.22 | 0.03 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 77.22 | 38.23 |
Price Performance
Historical ComparisonAbout ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.